☀️ AM Action: SRPT Cleared for Takeoff

The FDA told Sarepta Therapeutics to resume ELEVIDYS shipments for ambulatory Duchenne patients after completing a rapid safety review.

Brooks Dyroff&Casimir Stone

Jul 29, 2025

One trade idea here could pay for your subscription 10x.

We don’t cover fluff. We cover ideas that move portfolios. Upgrade now, before you miss your next trade